Outcomes of neonates with congenital heart disease

D B McElhinney1, G Wernovsky

  • 1Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia, and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

Insights

Outcomes for neonates with complex congenital heart disease are improving, with better survival rates and functional status. Advances in perioperative care are further enhancing prognosis for these young patients.

Area of Science:

  • Pediatric Cardiology
  • Neonatal Health
  • Congenital Heart Disease Outcomes

Background:

  • Significant advancements in pediatric cardiology over the last 10-15 years.
  • Recent publications focus on outcomes for neonates with congenital heart disease.
  • Congenital heart disease remains a critical area of neonatal health.

Purpose of the Study:

  • To review recent publications on outcomes in neonates with congenital heart disease.
  • To highlight improvements in survival and functional status.
  • To discuss developments in perioperative evaluation and management.

Main Methods:

  • Review of recent publications (past 18 months) on neonatal congenital heart disease outcomes.
  • Analysis of data on survival (preoperative, early postoperative, late postoperative).
  • Assessment of functional outcomes, including neurodevelopmental status.

Main Results:

  • Consistent improvement in survival rates for neonates with complex congenital heart defects.
  • New insights into late functional outcomes, particularly neurodevelopmental status.
  • Evidence of progress in managing complex neonatal heart conditions.

Conclusions:

  • Prognosis for neonates with complex congenital heart disease continues to improve.
  • Enhanced perioperative strategies are contributing to better patient outcomes.
  • Ongoing research and clinical advancements are vital for improving long-term results.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...